Cell-mediated immunity in patients with ovarian carcinoma.
D000951:Antigens, Neoplasm / Q000494:pharmacology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002464:Cell Migration Inhibition; D003536:Cystadenocarcinoma / Q000276:immunology*; D003537:Cystadenoma / Q000276:immunology*; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007044:Hysterectomy; D007111:Immunity, Cellular; D007890:Leiomyosarcoma / Q000276:immunology; D007962:Leukocytes; D009373:Neoplasms, Germ Cell and Embryonal / Q000276:immunology; D010051:Ovarian Neoplasms / Q000276:immunology*; D010053:Ovary / Q000601:surgery; D002583:Uterine Cervical Neoplasms / Q000276:immunology; D014594:Uterine Neoplasms / Q000276:immunology
D000951:Antigens, Neoplasm